Sucromate Equine is a specialized medication designed for the effective induction of ovulation in cyclic estrous mares. This treatment is specifically indicated for mares with an ovarian follicle size ranging between 30 and 40 mm in diameter. Using Sucromate Equine allows for ovulation to be induced within 48 hours of administration, helping breeders manage and optimize breeding schedules. Sucromate Equine contains a sterile, synthetic gonadotropin-releasing hormone (GnRH) analog, formulated as a sustained-release suspension. Upon intramuscular injection, the formulation forms an in situ gel, providing continuous release for improved efficacy.

Important Safety Information

As with any medical treatment, the use of Sucromate Equine may come with potential side effects. It is crucial to note that this product is intended solely for use in horses, specifically estrous mares, and should never be administered to humans. There are important precautions for pregnant women and women of childbearing age, as accidental exposure may disrupt menstrual cycles. For safety, Sucromate Equine is designed for intramuscular (IM) administration only; it must not be given intravascularly. Furthermore, it should not be administered more than once during a single heat cycle to avoid complications. Users should also be aware that injection site swelling may occur following administration, although these swellings typically resolve within five days.